Elena Rybakina has confirmed her first post-Australian Open tournament as the world No. 6 will return to Abu Dhabi between ...

The deal counter is buzzing with new funding rounds across sectors. This and more in todays ETtech Morning Dispatch.

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that ...

U.S. law firm Skadden, Arps, Slate, Meagher & Flom on Thursday said it has opened an office in Abu Dhabi, following other ...

Defiant is a new early stage VC firm focused on B2B SaaS and fintech coming out of stealth Thursday. Joseph Pizzolato ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, announced a multi-target collaboration with Novartis to identify and develop potentially first-in-class ...

The UAE Jiu-Jitsu Federation has announced the national team’s 2025 participation calendar. Sponsored by Mubadala Investment Company, the team is set to compete in nine championships from February to ...

Key Points - Sovereign-related investors, more commonly referred to as sovereign wealth funds, have increasingly made the Middle East ...

Tenvie Therapeutics launches with $200M, acquires Denali drug candidates, led by Tony Estrada with NLRP3 and SARM1 inhibitors ...

Backed by ARCH Venture Partners, F-Prime Capital and Mubadala Capital, the new company will develop a pipeline of ...

Tenvie Therapeutics is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug ...